| Current Price | $44.14 | Mkt Cap | $245.6B |
|---|---|---|---|
| Open | $44.07 | P/E Ratio | 9.83 |
| Prev. Close | $44.14 | Div. (Yield) | $1.60 (3.7%) |
| Daily Range | $43.49 - $44.28 | Volume | 22,825,792 |
| 52-Wk Range | $40.94 - $61.71 | Avg. Daily Vol. | 17,938,537 |
A research-based pharmaceutical company, Pfizer discovers, develops, manufactures, and markets prescription medicines such as Lipitor, Celebrex, and Viagra.
| Current Price | $44.14 | Mkt Cap | $245.6B |
|---|---|---|---|
| Open | $44.07 | P/E Ratio | 9.83 |
| Prev. Close | $44.14 | Div. (Yield) | $1.60 (3.7%) |
| Daily Range | $43.49 - $44.28 | Volume | 22,825,792 |
| 52-Wk Range | $40.94 - $61.71 | Avg. Daily Vol. | 17,938,537 |
The best Bull and Bear pitches based on recency and number of recommendations.
Has a solid moat with respect to COVID vaccines, and those will keep going potentially as far as the eye can see as long as the virus is with us. Pfizer also has a very wide range of drugs, a long history, and should do great over time.
Pfizer is a global leader in the bio pharmaceutical space, responsible for many of the most recognizable products on the market including epipen, viagara, Advil and others. Pfizer states their mission “is to become the world's most valued company to… More
Read the most recent pitches from players about PFE.
Recs
MFBriguy
(99.97)
Submitted: 7/6/2022 1:19:27 PM :
Start Price:
$51.81
NYSE:PFE Score:
+10.85
The data on C19 efficacy is bad and getting worse. The side effect data is bad and getting worse. The clinical trial data they submitted for emergency use and liabiility protection is littered with inconsistencies and mathematical gymnastics. If their liability protection is revoked, they could break their own record for largest judgement against in history.
Recs
raymond2017
(54.06)
Submitted: 6/22/2022 10:19:43 AM :
Start Price:
$47.68
NYSE:PFE Score:
-6.06
P/E of 10 and a dividend of 3.33% at it's present stock price. They also have plenty of cash due to the success of their Covid vaccines.
Recs
TMFrdownie
(41.12)
Submitted: 5/10/2022 6:46:25 PM :
Start Price:
$48.29
NYSE:PFE Score:
-0.69
Strong pipeline, wide moat, higher-than-average growth among large caps.
Find the members with the highest scoring picks in PFE.
flickib41 (59.75) Score: +179.69
The Score Leader is the player with the highest score across all their picks in PFE.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| compfreak999 | 78.85 | 6/20/2008 |
|
1Y | $10.04 | +339.58% | +187.60% | +151.98 | 1 Comment | |
| SomersGOP | < 20 | 6/23/2008 |
|
1Y | $10.08 | +337.81% | +186.37% | +151.44 | 0 Comment | |
| DrDrBob | 87.24 |
|
|
3Y | $10.08 | +337.81% | +186.37% | +151.44 | 0 Comment | |
| GracieMD1998 | < 20 | 6/23/2008 |
|
1Y | $10.08 | +337.81% | +186.37% | +151.44 | 0 Comment | |
| MATTALANKANE | 87.77 | 6/23/2008 |
|
5Y | $10.08 | +337.81% | +186.37% | +151.44 | 1 Comment | |
| eckertbt | < 20 | 6/23/2008 |
|
3Y | $10.08 | +337.81% | +186.37% | +151.44 | 1 Comment | |
| mooses2 | 50.80 | 6/23/2008 |
|
NS | $10.08 | +337.81% | +186.37% | +151.44 | 0 Comment | |
| gtmitc | 30.76 | 6/23/2008 |
|
1Y | $10.08 | +337.81% | +186.37% | +151.44 | 0 Comment | |
| AlIskandarani | 61.15 | 6/12/2008 |
|
1Y | $10.20 | +332.83% | +182.01% | +150.82 | 1 Comment | |
| megamillion2 | 68.23 | 6/12/2008 |
|
5Y | $10.20 | +332.83% | +182.01% | +150.82 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
